The global OTC and DTC Infectious Disease Diagnostic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of OTC and DTC Infectious Disease Diagnostic include Abbott, Bio-Rad Laboratories Inc, BD, Bosch Healthcare Solutions GmbH, Danaher, ThermoFisher Scientific, Siemens AG, Roche Holding AG and Hologic, Inc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
In the manufacture and quality control of medicinal products, compliance with the GMP rules is the decisive aspect for manufacturing high-quality products. For this reason, every staff member in the pharmaceutical industry has to be familiar with the basic GMP requirements
This report aims to provide a comprehensive presentation of the global market for OTC and DTC Infectious Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC and DTC Infectious Disease Diagnostic. This report contains market size and forecasts of OTC and DTC Infectious Disease Diagnostic in global, including the following market information:
Global OTC and DTC Infectious Disease Diagnostic Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the OTC and DTC Infectious Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OTC and DTC Infectious Disease Diagnostic Market, by Technology, 2018-2023, 2024-2029 ($ millions)
Global OTC and DTC Infectious Disease Diagnostic Market Segment Percentages, by Technology, 2022 (%)
PCR
Immunodiagnostics
Clinical Microbiology
INAAT
DNA Sequencing and NGS
DNA Microarrays
Others
Global OTC and DTC Infectious Disease Diagnostic Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global OTC and DTC Infectious Disease Diagnostic Market Segment Percentages, by Application, 2022 (%)
Diagnostic Laboratories
Hospitals and Clinics
Academic Research Institutes
Others
Global OTC and DTC Infectious Disease Diagnostic Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global OTC and DTC Infectious Disease Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC and DTC Infectious Disease Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies OTC and DTC Infectious Disease Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Bio-Rad Laboratories Inc
BD
Bosch Healthcare Solutions GmbH
Danaher
ThermoFisher Scientific
Siemens AG
Roche Holding AG
Hologic, Inc.
Qiagen
Cardinal Health
Quest Diagnostics Incorporated
Ador Diagnostics
Akonni Biosystems, Inc.
Alveo Technologies
Binx Health Inc.
bioMérieux, Inc.
Curetis
Sysmex Europe GmbH
Diasorin S.p.A
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC and DTC Infectious Disease Diagnostic, market overview.
Chapter 2: Global OTC and DTC Infectious Disease Diagnostic market size in revenue.
Chapter 3: Detailed analysis of OTC and DTC Infectious Disease Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by technology, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC and DTC Infectious Disease Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 OTC and DTC Infectious Disease Diagnostic Market Definition
1.2 Market Segments
1.2.1 Market by Technology
1.2.2 Market by Application
1.3 Global OTC and DTC Infectious Disease Diagnostic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global OTC and DTC Infectious Disease Diagnostic Overall Market Size
2.1 Global OTC and DTC Infectious Disease Diagnostic Market Size: 2022 VS 2029
2.2 Global OTC and DTC Infectious Disease Diagnostic Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top OTC and DTC Infectious Disease Diagnostic Players in Global Market
3.2 Top Global OTC and DTC Infectious Disease Diagnostic Companies Ranked by Revenue
3.3 Global OTC and DTC Infectious Disease Diagnostic Revenue by Companies
3.4 Top 3 and Top 5 OTC and DTC Infectious Disease Diagnostic Companies in Global Market, by Revenue in 2022
3.5 Global Companies OTC and DTC Infectious Disease Diagnostic Product Type
3.6 Tier 1, Tier 2 and Tier 3 OTC and DTC Infectious Disease Diagnostic Players in Global Market
3.6.1 List of Global Tier 1 OTC and DTC Infectious Disease Diagnostic Companies
3.6.2 List of Global Tier 2 and Tier 3 OTC and DTC Infectious Disease Diagnostic Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Technology - Global OTC and DTC Infectious Disease Diagnostic Market Size Markets, 2022 & 2029
4.1.2 PCR
4.1.3 Immunodiagnostics
4.1.4 Clinical Microbiology
4.1.5 INAAT
4.1.6 DNA Sequencing and NGS
4.1.7 DNA Microarrays
4.1.8 Others
4.2 By Technology - Global OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts
4.2.1 By Technology - Global OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2023
4.2.2 By Technology - Global OTC and DTC Infectious Disease Diagnostic Revenue, 2024-2029
4.2.3 By Technology - Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global OTC and DTC Infectious Disease Diagnostic Market Size, 2022 & 2029
5.1.2 Diagnostic Laboratories
5.1.3 Hospitals and Clinics
5.1.4 Academic Research Institutes
5.1.5 Others
5.2 By Application - Global OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts
5.2.1 By Application - Global OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2023
5.2.2 By Application - Global OTC and DTC Infectious Disease Diagnostic Revenue, 2024-2029
5.2.3 By Application - Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global OTC and DTC Infectious Disease Diagnostic Market Size, 2022 & 2029
6.2 By Region - Global OTC and DTC Infectious Disease Diagnostic Revenue & Forecasts
6.2.1 By Region - Global OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2023
6.2.2 By Region - Global OTC and DTC Infectious Disease Diagnostic Revenue, 2024-2029
6.2.3 By Region - Global OTC and DTC Infectious Disease Diagnostic Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2029
6.3.2 US OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.3.3 Canada OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.3.4 Mexico OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2029
6.4.2 Germany OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4.3 France OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4.4 U.K. OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4.5 Italy OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4.6 Russia OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4.7 Nordic Countries OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.4.8 Benelux OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2029
6.5.2 China OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.5.3 Japan OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.5.4 South Korea OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.5.5 Southeast Asia OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.5.6 India OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2029
6.6.2 Brazil OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.6.3 Argentina OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa OTC and DTC Infectious Disease Diagnostic Revenue, 2018-2029
6.7.2 Turkey OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.7.3 Israel OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.7.4 Saudi Arabia OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
6.7.5 UAE OTC and DTC Infectious Disease Diagnostic Market Size, 2018-2029
7 OTC and DTC Infectious Disease Diagnostic Companies Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.1.4 Abbott OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.1.5 Abbott Key News & Latest Developments
7.2 Bio-Rad Laboratories Inc
7.2.1 Bio-Rad Laboratories Inc Company Summary
7.2.2 Bio-Rad Laboratories Inc Business Overview
7.2.3 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.2.4 Bio-Rad Laboratories Inc OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.2.5 Bio-Rad Laboratories Inc Key News & Latest Developments
7.3 BD
7.3.1 BD Company Summary
7.3.2 BD Business Overview
7.3.3 BD OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.3.4 BD OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.3.5 BD Key News & Latest Developments
7.4 Bosch Healthcare Solutions GmbH
7.4.1 Bosch Healthcare Solutions GmbH Company Summary
7.4.2 Bosch Healthcare Solutions GmbH Business Overview
7.4.3 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.4.4 Bosch Healthcare Solutions GmbH OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.4.5 Bosch Healthcare Solutions GmbH Key News & Latest Developments
7.5 Danaher
7.5.1 Danaher Company Summary
7.5.2 Danaher Business Overview
7.5.3 Danaher OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.5.4 Danaher OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.5.5 Danaher Key News & Latest Developments
7.6 ThermoFisher Scientific
7.6.1 ThermoFisher Scientific Company Summary
7.6.2 ThermoFisher Scientific Business Overview
7.6.3 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.6.4 ThermoFisher Scientific OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.6.5 ThermoFisher Scientific Key News & Latest Developments
7.7 Siemens AG
7.7.1 Siemens AG Company Summary
7.7.2 Siemens AG Business Overview
7.7.3 Siemens AG OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.7.4 Siemens AG OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.7.5 Siemens AG Key News & Latest Developments
7.8 Roche Holding AG
7.8.1 Roche Holding AG Company Summary
7.8.2 Roche Holding AG Business Overview
7.8.3 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.8.4 Roche Holding AG OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.8.5 Roche Holding AG Key News & Latest Developments
7.9 Hologic, Inc.
7.9.1 Hologic, Inc. Company Summary
7.9.2 Hologic, Inc. Business Overview
7.9.3 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.9.4 Hologic, Inc. OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.9.5 Hologic, Inc. Key News & Latest Developments
7.10 Qiagen
7.10.1 Qiagen Company Summary
7.10.2 Qiagen Business Overview
7.10.3 Qiagen OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.10.4 Qiagen OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.10.5 Qiagen Key News & Latest Developments
7.11 Cardinal Health
7.11.1 Cardinal Health Company Summary
7.11.2 Cardinal Health Business Overview
7.11.3 Cardinal Health OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.11.4 Cardinal Health OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.11.5 Cardinal Health Key News & Latest Developments
7.12 Quest Diagnostics Incorporated
7.12.1 Quest Diagnostics Incorporated Company Summary
7.12.2 Quest Diagnostics Incorporated Business Overview
7.12.3 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.12.4 Quest Diagnostics Incorporated OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.12.5 Quest Diagnostics Incorporated Key News & Latest Developments
7.13 Ador Diagnostics
7.13.1 Ador Diagnostics Company Summary
7.13.2 Ador Diagnostics Business Overview
7.13.3 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.13.4 Ador Diagnostics OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.13.5 Ador Diagnostics Key News & Latest Developments
7.14 Akonni Biosystems, Inc.
7.14.1 Akonni Biosystems, Inc. Company Summary
7.14.2 Akonni Biosystems, Inc. Business Overview
7.14.3 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.14.4 Akonni Biosystems, Inc. OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.14.5 Akonni Biosystems, Inc. Key News & Latest Developments
7.15 Alveo Technologies
7.15.1 Alveo Technologies Company Summary
7.15.2 Alveo Technologies Business Overview
7.15.3 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.15.4 Alveo Technologies OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.15.5 Alveo Technologies Key News & Latest Developments
7.16 Binx Health Inc.
7.16.1 Binx Health Inc. Company Summary
7.16.2 Binx Health Inc. Business Overview
7.16.3 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.16.4 Binx Health Inc. OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.16.5 Binx Health Inc. Key News & Latest Developments
7.17 bioMérieux, Inc.
7.17.1 bioMérieux, Inc. Company Summary
7.17.2 bioMérieux, Inc. Business Overview
7.17.3 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.17.4 bioMérieux, Inc. OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.17.5 bioMérieux, Inc. Key News & Latest Developments
7.18 Curetis
7.18.1 Curetis Company Summary
7.18.2 Curetis Business Overview
7.18.3 Curetis OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.18.4 Curetis OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.18.5 Curetis Key News & Latest Developments
7.19 Sysmex Europe GmbH
7.19.1 Sysmex Europe GmbH Company Summary
7.19.2 Sysmex Europe GmbH Business Overview
7.19.3 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.19.4 Sysmex Europe GmbH OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.19.5 Sysmex Europe GmbH Key News & Latest Developments
7.20 Diasorin S.p.A
7.20.1 Diasorin S.p.A Company Summary
7.20.2 Diasorin S.p.A Business Overview
7.20.3 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Major Product Offerings
7.20.4 Diasorin S.p.A OTC and DTC Infectious Disease Diagnostic Revenue in Global Market (2018-2023)
7.20.5 Diasorin S.p.A Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
116
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
112
|
View Report
Price : US
$3250
|
Date :
May 2023
|
CAT ID :
7
|
Pages :
115
|
View Report